[
    [
        {
            "time": "",
            "original_text": "热门公司调研机构云集，34家看涨逾100%。",
            "features": {
                "keywords": [
                    "热门公司",
                    "调研机构",
                    "看涨"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "热门公司调研机构云集，34家看涨逾100%。",
                "Correlation": 6,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 6,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "长春高新：公司收购的“脑脊液AD诊断试剂盒”和“外周血AD诊断试剂盒”非免临床项目。",
            "features": {
                "keywords": [
                    "长春高新",
                    "脑脊液AD诊断试剂盒",
                    "外周血AD诊断试剂盒",
                    "非免临床项目"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "长春高新：公司收购的“脑脊液AD诊断试剂盒”和“外周血AD诊断试剂盒”非免临床项目。",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "长春高新：公司目前生产经营正常。",
            "features": {
                "keywords": [
                    "长春高新",
                    "生产经营正常"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "长春高新：公司目前生产经营正常。",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 4,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "长春高新：子公司华康药业主要从事中药的研发、生产和销售，涵盖心脑血管、中药抗炎及妇儿等产品线。",
            "features": {
                "keywords": [
                    "长春高新",
                    "华康药业",
                    "中药",
                    "心脑血管",
                    "抗炎",
                    "妇儿产品线"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "中药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "长春高新：子公司华康药业主要从事中药的研发、生产和销售，涵盖心脑血管、中药抗炎及妇儿等产品线。",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 5,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "公司有无计划进军玻尿酸业务？长春高新：目前暂无相关规划。",
            "features": {
                "keywords": [
                    "长春高新",
                    "玻尿酸",
                    "暂无规划"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "公司有无计划进军玻尿酸业务？长春高新：目前暂无相关规划。",
                "Correlation": 8,
                "Sentiment": 4,
                "Importance": 5,
                "Impact": 4,
                "Duration": 4,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "长春高新：公司贯彻以医药为主、房地产为辅的产业发展定位，努力提升发展质量和速度，增强发展效益，实现企业规模实力持续增长。",
            "features": {
                "keywords": [
                    "长春高新",
                    "医药为主",
                    "房地产为辅",
                    "发展质量",
                    "发展速度",
                    "规模实力增长"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "房地产"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "长春高新：公司贯彻以医药为主、房地产为辅的产业发展定位，努力提升发展质量和速度，增强发展效益，实现企业规模实力持续增长。",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "长春高新：截至目前公司直接持有百克生物17,148.82万股股份，占百克生物总股本的41.54%，是百克生物的控股股东。",
            "features": {
                "keywords": [
                    "长春高新",
                    "百克生物",
                    "控股",
                    "41.54%"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "长春高新：截至目前公司直接持有百克生物17,148.82万股股份，占百克生物总股本的41.54%，是百克生物的控股股东。",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]